These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4650125)

  • 1. Cyclopropane analogues to acetylenic oxotremorine antagonists.
    Grundström K; Dahlbom R
    Acta Pharm Suec; 1972 Nov; 9(5):491-8. PubMed ID: 4650125
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylene compounds of potential pharmacological value. XXIX. Stereoselectivity of N-(1-alkyl-4-pyrrolidino-2-butynyl)-substituted 2-pyrrolidones and succinimides as oxotremorine antagonists.
    Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1979; 16(1):13-20. PubMed ID: 452907
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetylene compounds of potential pharmacological value. XXI. Further studies on the effect of branching the intermediate chain of N-(t-aminoalkynyl)-substituted succinimides and 2-pyrrolidones.
    Ringdahl B; Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(4):297-304. PubMed ID: 1199731
    [No Abstract]   [Full Text] [Related]  

  • 4. Acetylene compounds of potential pharmacological value. XIX. N-(dialkylaminoalkynyl)-substituted succinimides and 2-pyrrolidones as partial cholinergic agonists.
    Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(3):209-14. PubMed ID: 1163240
    [No Abstract]   [Full Text] [Related]  

  • 5. Acetylene compounds of potential pharmacological value. XXX. Synthesis and pharmacological properties of N-(4-pyrrolidino-2-pentynyl)-substituted 2-pyrrolidone and succinimide.
    Resul B; Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1979; 16(3):161-5. PubMed ID: 484249
    [No Abstract]   [Full Text] [Related]  

  • 6. Stereospecificity of oxotremorine antagonists.
    Dahlbom R; Lindquist A; Lindgren S; Svensson U; Ringdahl B; Blair MR
    Experientia; 1974 Oct; 30(10):1165-7. PubMed ID: 4435124
    [No Abstract]   [Full Text] [Related]  

  • 7. Acetylene compounds of potential pharmacological value. 18. N-(t-aminoalkynyl)-substituted 2-pyrrolidones, a new series of potent oxotremorine antagonists.
    Lindgren S; Lindquist A; Lindeke B; Svensson U; Karlén B; Dahlbom R
    Acta Pharm Suec; 1973 Dec; 10(6):435-40. PubMed ID: 4773112
    [No Abstract]   [Full Text] [Related]  

  • 8. Acetylene compounds of potential pharmacological value. XVI. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl)succinimides.
    Lindquist A; Lindgren S; Lindeke B; Karlén B; Dahlbom R; Blair MR
    Acta Pharm Suec; 1972 Apr; 9(2):93-8. PubMed ID: 5030544
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylene compounds of potential pharmacological value. XXIII. N-(1-Methyl-5-pyrrolidino-3-pentynyl)-substituted succinimide and 2-pyrrolidone.
    Lindgren S; Svensson U; Dahlbom R
    Acta Pharm Suec; 1975; 12(5-6):503-6. PubMed ID: 1217504
    [No Abstract]   [Full Text] [Related]  

  • 10. Acetylene compounds of potential pharmacological value. XXII. Base strength and biological activity in oxotremorine antagonists.
    Svensson U; Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1975; 12(5-6):393-400. PubMed ID: 1217491
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylene compounds of potential pharmacological value. XXVII. Stereoselectivity of oxotremorine antagonists containing a chiral pyrrolidine group.
    Ringdahl B; Dahlbom R
    Acta Pharm Suec; 1978; 15(4):255-63. PubMed ID: 726907
    [No Abstract]   [Full Text] [Related]  

  • 12. The central and peripheral effectiveness of two oxotremorine-antagonists determined using oxotremorine-induced tremor and salivation.
    Eicholzer A; Ogren SO
    J Pharm Pharmacol; 1977 Oct; 29(10):609-11. PubMed ID: 21240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-(perhydroazepinoalkynyl)- and N-(perhydroazocinoalkynyl) succinimides as oxotremorine antagonists.
    Lindqvist A; Lindgren S; Lindeke B; Karlén B; Dahlbom R; Blair MR
    J Pharm Pharmacol; 1970 Sep; 22(9):707-8. PubMed ID: 4395168
    [No Abstract]   [Full Text] [Related]  

  • 14. Stereoselectivity of some oxotremorine antagonists containing two chiral centres.
    Ringdahl B; Resul B; Dahlbom R
    J Pharm Pharmacol; 1979 Dec; 31(12):837-9. PubMed ID: 43369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of distribution as a determinant of central anticholinergic specificity in a series of oxotremorine analogs.
    Karlén B; Jenden DJ
    Res Commun Chem Pathol Pharmacol; 1970 Jul; 1(4):471-8. PubMed ID: 5524258
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of 1-(2-oxo-1-pyrrolidino)-4-(2-chloroethyl-methylamino)but-2-yne-HCl (DSO-16), I. Its central cholinomimetic and cholinolytic effects on mice.
    György L; Gellén B; Dóda M; Sterk L
    Acta Physiol Acad Sci Hung; 1971; 40(3):373-9. PubMed ID: 5147960
    [No Abstract]   [Full Text] [Related]  

  • 17. The conversion of 2-chloroalkylamine analogues of oxotremorine to aziridinium ions and their interactions with muscarinic receptors in the guinea pig ileum.
    Ringdahl B; Resul B; Ehlert FJ; Jenden DJ; Dahlbom R
    Mol Pharmacol; 1984 Sep; 26(2):170-9. PubMed ID: 6332977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymic oxidation alpha to the acetylenic group in the metabolism of N-(5-pyrrolidinopent-3-ynyl)-succinimide (BL 14) in vitro.
    Lindeke B; Hallström G; Anderson E
    Xenobiotica; 1978 Jun; 8(6):341-8. PubMed ID: 676341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta-adrenergic blocking agents, with differing ancillary properties on oxotremorine induced tremor in mice.
    Alkondon M; Ray A; Sen P
    Indian J Exp Biol; 1984 Jul; 22(7):382-3. PubMed ID: 6150896
    [No Abstract]   [Full Text] [Related]  

  • 20. Pyrrolidinones as potent functional antagonists of the human melanocortin-4 receptor.
    Jiang W; Tucci FC; Tran JA; Fleck BA; Wen J; Markison S; Marinkovic D; Chen CW; Arellano M; Hoare SR; Johns M; Foster AC; Saunders J; Chen C
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5610-3. PubMed ID: 17822895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.